Fogo AB - Search Results

1

The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury.

Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB. Yang HC, et al. Among authors: fogo ab. J Am Soc Nephrol. 2009 Nov;20(11):2380-8. doi: 10.1681/ASN.2008111138. Epub 2009 Oct 1. J Am Soc Nephrol. 2009. PMID: 19797472 Free PMC article.

2

Functional significance of leukotriene B4 in normal and glomerulonephritic kidneys.

Yared A, Albrightson-Winslow C, Griswold D, Takahashi K, Fogo A, Badr KF. Yared A, et al. J Am Soc Nephrol. 1991 Jul;2(1):45-56. doi: 10.1681/ASN.V2145. J Am Soc Nephrol. 1991. PMID: 1655093

3

Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality.

Yoshioka T, Ichikawa I, Fogo A. Yoshioka T, et al. J Am Soc Nephrol. 1991 Oct;2(4):902-12. doi: 10.1681/ASN.V24902. J Am Soc Nephrol. 1991. PMID: 1721553

4

Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity.

Hunley TE, Fogo A, Iwasaki S, Kon V. Hunley TE, et al. J Am Soc Nephrol. 1995 Mar;5(9):1718-23. doi: 10.1681/ASN.V591718. J Am Soc Nephrol. 1995. PMID: 7780063

5

Renin-angiotensin genes in renal development and the occurrence and progression of renal diseases.

Hohenfellner K, Fogo A, Kon V. Hohenfellner K, et al. Semin Nephrol. 1999 Mar;19(2):148-54. Semin Nephrol. 1999. PMID: 10192247 Review.

6

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.

Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Nakamura S, et al. Among authors: fogo ab. Kidney Int. 2000 Jul;58(1):251-9. doi: 10.1046/j.1523-1755.2000.00160.x. Kidney Int. 2000. PMID: 10886570 Free article.

7

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.

Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB. Brown NJ, et al. Among authors: fogo ab. Kidney Int. 2000 Sep;58(3):1219-27. doi: 10.1046/j.1523-1755.2000.00277.x. Kidney Int. 2000. PMID: 10972684 Free article.

8

Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.

Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB. Ma LJ, et al. Among authors: fogo ab. Kidney Int. 2000 Dec;58(6):2425-36. doi: 10.1046/j.1523-1755.2000.00426.x. Kidney Int. 2000. PMID: 11115076 Free article.

9

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB. Ma LJ, et al. Among authors: fogo ab. Kidney Int. 2001 May;59(5):1899-910. doi: 10.1046/j.1523-1755.2001.0590051899.x. Kidney Int. 2001. PMID: 11318962 Free article.

10

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.

Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE. Kaikita K, et al. Among authors: fogo ab. Circulation. 2001 Aug 14;104(7):839-44. doi: 10.1161/hc3301.092803. Circulation. 2001. PMID: 11502712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters